ARCHIVES

Evidence Too Weak to Link Agent Orange, Cancer, IOM Says

This article is from The Cancer Letter archive.

Vol. 28 No. 12 | March 22, 2002

Download PDF Visit The Full Archive

Related Articles

FDA carries Action On Two Cancer Drugs Over To 1996

January 5, 1996

Compendium Drops Listing of Aranesp for Anemia of Cancer.

February 23, 2007

Bush Asks Hammer To Probe FDA Regulation Of Anticancer Drugs

June 17, 1988

Afinitor Delayed Progression Compared To Tamoxifen Alone In Randomized Phase II Study

December 31, 2010

Cancer Program Advocates Seek $170 Mil. Above President’s Budget, Vow To Close Bypass Gap

May 8, 1992

Panel Recommends Peer Review “Fine Tuning” Changes Including Mandatory Service By All NIH Grantees

January 6, 1984